• 3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments

    20 days ago - By Xconomy

    Three biotech companies collectively raised $584 million in their initial public offerings last week, continuing a streak of IPOs that has the healthcare sector playing a leading role in the robust level of market activity this summer. Of the three companies, the one with investigational therapies that haven't yet begun being tested in humans raised the most. South San Francisco-based Nkarta collected $252 million, money the preclinical firm plans to use to get its lead allogenic, or “off-the-shelf,” cancer therapy into the clinic by year's end and to advance its earlier programs. The...
    Read more ...